Atul Limited. — M&A Activity 2021

Mar 13, 2021

==> picture [44 x 43] intentionally omitted <==

==> picture [57 x 36] intentionally omitted <==

a)	nameofthetargetentity, details in briefsuch as size,turnoveretc.;	Atul Lifescience Ltd (ALSL)Authorised - ~50,000Paid up capital- amountisyet to be investedTurnover- NIL (yettocommence businessoperations)
b)	whetherthe acquisitionwouldfallwithinrelatedpartytransaction(s)andw hetherthepromoter/promotergroup/groupcompanieshaveanyinterest in theentitybeing acquired? If yes, natureofinterestanddetailsthereofandw hether the sameisdoneat"arm'slength";	It is a related party.PromoterIpromotergroupIpromoter groupcompanies have nointerest in theabove.
c)	industrytowhich the entity being acquiredbelongs;objectsandeffectsofacquisition (includingbut not limited to,disclosureofreasonsforacquisitionoftargetentity,ifits business is	Lifescience Chemicals and APls.
d)		ManufacturingofLifescience Chemicals andAPis.

==> picture [44 x 45] intentionally omitted <==

==> picture [57 x 23] intentionally omitted <==

e)f)	outside themainlineofbusinessofthelisted entity);
	brief detailsofanygovernmentalorregulatoryapprovals requiredfortheacquisition;	None
	indicativetimeperiodforcompletionoftheacquisition;	Notapplicable
g)	natureofconsideration - whethercashconsiderationorshareswapanddetailsofthe same;	Cash consideration
h)	costofacquisitionorthe priceatwhichtheshares are acquired;	Amountisyettobeinvested
i)	percentageofshareholding_I_controlacquiredand_I_ornumberofsharesacquired;	100%
j)	brief backgroundabouttheentityacquiredin termsofproducts/lineofbusinessacquired, dateofincorporation, historyoflast3 yearsturnover,country inwhichtheacquiredentityhaspresence andanyother significantinformation(inbrief);	Subjecttorequired approvals, ALSLwillundertakenewprojectofaround~104erbyacombinationofdebtand capitalforAPIintermediates.Last 3 years Turnover- nilCountry:India